There’s a new development in the proposed settlement between Bayer and plaintiffs over the alleged link between glyphosate and cancer. A federal judge questioned Bayer’s plan to resolve future claims through the use of an independent panel of scientific experts. As a result, Bayer has withdrawn its settlement agreement and will consider adjustments for the handling of future claims. The decision does not affect the broader settlement agreement for the current lawsuits associated with Roundup.
Subscribe to RRFN
Get a weekly digest from RRFN to stay up-to-date on all the latest news in agriculture.